Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.

Kayesh MEH, Ezzikouri S, Sanada T, Chi H, Hayashi Y, Rebbani K, Kitab B, Matsuu A, Miyoshi N, Hishima T, Kohara M, Tsukiyama-Kohara K.

Sci Rep. 2017 Aug 29;7(1):9848. doi: 10.1038/s41598-017-10329-7.

3.

A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection.

Li X, Gu Y, Guo X, Gu L, Zhou L, Wu X, Wang X, Stamataki Z, Huang Y.

Sci Rep. 2017 Jul 19;7(1):5866. doi: 10.1038/s41598-017-06192-1.

4.

Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C.

López-Rodríguez R, Hernández-Bartolomé Á, Borque MJ, Rodríguez-Muñoz Y, Martín-Vílchez S, García-Buey L, González-Moreno L, Real-Martínez Y, Muñoz de Rueda P, Salmerón J, Vidal-Castiñeira JR, López-Larrea C, Rodrigo L, Moreno-Otero R, Sanz-Cameno P.

PLoS One. 2017 Jul 12;12(7):e0180927. doi: 10.1371/journal.pone.0180927. eCollection 2017.

5.

Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.

Yang CM, Yoon JC, Park JH, Lee JM.

PLoS One. 2017 Apr 14;12(4):e0175793. doi: 10.1371/journal.pone.0175793. eCollection 2017.

6.

CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.

Judge CJ, Kostadinova L, Sherman KE, Butt AA, Falck-Ytter Y, Funderburg NT, Landay AL, Lederman MM, Sieg SF, Sandberg JK, Anthony DD.

J Leukoc Biol. 2017 Jul;102(1):171-184. doi: 10.1189/jlb.5A1116-456R. Epub 2017 Apr 11.

PMID:
28400540
7.

Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.

Cramer ML, Shao G, Rodino-Klapac LR, Chicoine LG, Martin PT.

Hum Gene Ther. 2017 Jun;28(6):493-509. doi: 10.1089/hum.2016.113. Epub 2017 Mar 23.

PMID:
28345428
8.

Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity.

Fukuhara T, Yamamoto S, Ono C, Nakamura S, Motooka D, Mori H, Kurihara T, Sato A, Tamura T, Motomura T, Okamoto T, Imamura M, Ikegami T, Yoshizumi T, Soejima Y, Maehara Y, Chayama K, Matsuura Y.

Sci Rep. 2017 Mar 22;7:45228. doi: 10.1038/srep45228.

9.

Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model.

Ojiro K, Qu X, Cho H, Park JJ, Vuidepot A, Lissin N, Molloy PE, Bennett A, Jakobsen BK, Kaplan DE, Riley JL, Chang KM.

J Virol. 2017 Apr 28;91(10). pii: e02129-16. doi: 10.1128/JVI.02129-16. Print 2017 May 15.

PMID:
28275182
10.

Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.

Bhattarai N, McLinden JH, Xiang J, Mathahs MM, Schmidt WN, Kaufman TM, Stapleton JT.

PLoS Pathog. 2017 Feb 24;13(2):e1006232. doi: 10.1371/journal.ppat.1006232. eCollection 2017 Feb.

11.

Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism.

Asadi-Saghandi A, Shams A, Eslami G, Mirghanizadeh SA, Eskandari-Nasab E.

Virusdisease. 2016 Dec;27(4):369-374. doi: 10.1007/s13337-016-0349-1. Epub 2016 Sep 28.

PMID:
28004016
12.

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.

Hernández-Bartolomé Á, López-Rodríguez R, Borque MJ, González-Moreno L, Real-Martínez Y, García-Buey L, Moreno-Otero R, Sanz-Cameno P.

World J Gastroenterol. 2016 Nov 28;22(44):9744-9751.

13.

The Strange, Expanding World of Animal Hepaciviruses.

Hartlage AS, Cullen JM, Kapoor A.

Annu Rev Virol. 2016 Sep 29;3(1):53-75.

14.

Immune-Enhancing Effects of a High Molecular Weight Fraction of Cynanchum wilfordii Hemsley in Macrophages and Immunosuppressed Mice.

Jang M, Lim TG, Ahn S, Hong HD, Rhee YK, Kim KT, Lee E, Lee JH, Lee YJ, Jung CS, Lee DY, Cho CW.

Nutrients. 2016 Sep 27;8(10). pii: E600.

15.

Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.

Naggie S, Holland DP, Sulkowski MS, Thomas DL.

Clin Infect Dis. 2017 Jan 1;64(1):92-99. Epub 2016 Sep 28.

PMID:
27682067
16.

Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.

Honegger JR, Tedesco D, Kohout JA, Prasad MR, Price AA, Lindquist T, Ohmer S, Moore-Clingenpeel M, Grakoui A, Walker CM.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10684-9. doi: 10.1073/pnas.1602337113. Epub 2016 Sep 6.

17.

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Swadling L, Halliday J, Kelly C, Brown A, Capone S, Ansari MA, Bonsall D, Richardson R, Hartnell F, Collier J, Ammendola V, Del Sorbo M, Von Delft A, Traboni C, Hill AV, Colloca S, Nicosia A, Cortese R, Klenerman P, Folgori A, Barnes E.

Vaccines (Basel). 2016 Aug 2;4(3). pii: E27. doi: 10.3390/vaccines4030027.

18.

A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.

Zhang YH, Zhao Y, Rajapaksa US, Lawrence TM, Peng YC, Liu J, Xu K, Hu K, Qin L, Liu N, Sun H, Yan HP, Repapi E, Rowland-Jones S, Thimme R, McKeating JA, Dong T.

PLoS One. 2016 Jul 25;11(7):e0158037. doi: 10.1371/journal.pone.0158037. eCollection 2016.

19.

Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.

Agrawal B, Kumar R.

World J Gastroenterol. 2016 Jul 7;22(25):5623-6. doi: 10.3748/wjg.v22.i25.5623.

20.

Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner.

Pfaender S, Grabski E, Detje CN, Riebesehl N, Lienenklaus S, Steinmann E, Kalinke U, Pietschmann T.

PLoS Pathog. 2016 Jul 6;12(7):e1005736. doi: 10.1371/journal.ppat.1005736. eCollection 2016 Jul.

Supplemental Content

Support Center